Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model

Immune modulators such as anti-thymoglobulin (ATG) are under clinical evaluation for the treatment of type 1 diabetes (T1D). Although such agents have cured T1D in the non-obese diabetic (NOD) model, their clinical efficacy has been much lower. In order to improve the odds of successful translation...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Clinical and experimental immunology Ročník 163; číslo 3; s. 375 - 380
Hlavní autori: Bresson, D, von Herrath, M.G
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Oxford, UK Blackwell Publishing Ltd 01.03.2011
Blackwell
Oxford University Press
Blackwell Science Inc
Predmet:
Rat
ISSN:0009-9104, 1365-2249, 1365-2249
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Buďte prvý, kto okomentuje tento záznam!
Najprv sa musíte prihlásiť.